Build status - In Progress
Infusion System for Hepatic Cancer
Recruiting
18 years - 99 years
All
Phase
N/A
100 participants needed
1 Location
Brief description of study
The primary objective is to assess the safety of using the Medtronic Pump with the Codman catheter for hepatic artery infusion (HAI) using a standard chemotherapy drug.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Hepatic Cancer,Liver Cancer
-
Age: 18 years - 99 years
-
Gender: All
Male or Female, Age 18 or older, Have a clinical or biopsy-proven diagnosis of colorectal cancer metastatic to liver or intrahepatic cholangiocarcinoma
Updated on
04 Aug 2024.
Study ID: 844166
Find a site
,
Your Information has been sent successfully.
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up
Send a message
Enter your contact details to connect with study team
Primary Contact
Interested in the study
Select a study center that’s convenient for you, and get in touch with the study team.
Contact a study centerPlease choose between Voice or SMS based delivery of verification code
or